Profile data is unavailable for this security.
About the company
Katakura Industries Co.,Ltd. is a Japan-based company mainly engaged in the real estate operation and leasing, as well as the manufacture and sale of mechanical maintenance products and auto parts. The Company operates through four business segments. The Textile segment is engaged in the manufacture and sale of underwear, socks, silk products, casual innerwear, adjusted underwear and functional fibers, as well as the brand licensing business. The Pharmaceutical segment manufactures and sells ethical drugs. The Machinery-Related segment manufactures and sells fire trucks, automobile parts, agricultural machinery and imports and sells petroleum products. The Real Estate segment operates shopping centers and rents real estate. The Company is also involved in the home improvement, building management services, sales of flower visiting insects, low potassium lettuce, production and sales of Hanabiratake and day services.
- Revenue in JPY (TTM)39.01bn
- Net income in JPY2.90bn
- Incorporated1920
- Employees1.04k
- LocationKatakura Industries Co LtdNichirei Akashicho Bldg.6-4, Akashi-choCHUO-KU 104-8312JapanJPN
- Phone+81 368321873
- Fax+81 368320256
- Websitehttps://www.katakura.co.jp/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinuvel Pharmaceuticals Limited | 9.60bn | 3.58bn | 68.91bn | 16.00 | 19.53 | 3.38 | 18.65 | 7.18 | 0.7014 | 0.7014 | 1.87 | 4.05 | 0.4496 | -0.1099 | 3.94 | -- | 16.78 | 18.81 | 19.05 | 21.04 | 101.16 | 102.61 | 37.31 | 39.00 | 8.39 | 10.94 | 0.0043 | 7.42 | 16.15 | 24.75 | 16.44 | 14.47 | 84.96 | 14.87 |
| Jiangsu Lianhuan Pharmaceutical Co. Ltd | 49.65bn | 2.95bn | 69.19bn | 1.30k | 23.43 | 2.32 | -- | 1.39 | 0.4865 | 0.4865 | 8.18 | 4.92 | 0.8003 | 3.34 | 4.76 | 1,801,909.00 | 5.42 | 5.93 | 11.26 | 11.25 | 49.14 | 53.26 | 6.78 | 7.82 | 0.7061 | 6.61 | 0.3593 | 30.64 | 11.20 | 16.36 | -4.50 | 12.91 | 9.35 | 13.97 |
| Amylyx Pharmaceuticals Inc | 45.60bn | -25.32bn | 69.63bn | 384.00 | -- | 1.75 | -- | 1.53 | -2.45 | -2.45 | 4.34 | 3.84 | 0.7605 | 3.69 | 15.91 | 778,026.10 | -42.22 | -- | -50.91 | -- | 84.64 | -- | -55.52 | -- | 4.66 | -- | 0.00 | -- | 1,612.94 | -- | 124.84 | -- | -- | -- |
| ChengDu Sheng Nuo Biotec Co Ltd | 10.24bn | 1.97bn | 70.04bn | 1.13k | 35.52 | 3.59 | -- | 6.84 | 0.8279 | 0.8279 | 4.31 | 8.20 | 0.3401 | 0.862 | 3.96 | 426,977.70 | 6.52 | 7.47 | 8.67 | 9.44 | 59.92 | 70.52 | 19.17 | 15.82 | 0.8466 | 13.35 | 0.32 | 21.83 | 9.93 | 9.37 | 9.08 | 18.69 | 54.71 | -- |
| Katakura Industries Co., Ltd. | 39.01bn | 2.90bn | 71.66bn | 1.04k | 23.17 | 0.8751 | 12.39 | 1.84 | 87.82 | 87.82 | 1,179.69 | 2,325.40 | 0.2783 | 2.21 | 5.10 | 37,506,730.00 | 2.19 | 2.35 | 2.82 | 3.34 | 38.25 | 37.75 | 7.87 | 8.32 | 2.71 | -- | 0.1076 | 18.81 | 16.62 | -2.04 | 8.09 | 18.87 | -7.46 | 10.76 |
| Zevra Therapeutics Inc | 3.66bn | -10.04bn | 72.28bn | 65.00 | -- | 11.64 | -- | 19.74 | -1.67 | -1.67 | 0.6106 | 0.7734 | 0.1919 | -- | 2.09 | 369,015.40 | -52.61 | -32.11 | -65.34 | -39.89 | 71.78 | -- | -274.10 | -128.42 | -- | -112.94 | 0.6423 | -- | 170.26 | -- | -72.00 | -- | 69.75 | -- |
| Blau Farmaceutica SA | 44.84bn | 4.98bn | 72.68bn | 1.90k | 14.61 | 1.29 | 11.67 | 1.62 | 1.04 | 1.04 | 9.40 | 11.80 | 0.5339 | 1.82 | 3.59 | 887,276.30 | 5.81 | 16.01 | 6.79 | 19.59 | 35.38 | 44.57 | 10.88 | 21.99 | 2.27 | 13.12 | 0.2086 | 16.61 | -2.44 | 11.91 | -31.14 | 15.18 | 38.96 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 02 Oct 2024 | 686.84k | 1.95% |
| Nomura Asset Management Co., Ltd.as of 03 Oct 2024 | 567.80k | 1.61% |
| Zennor Asset Management LLPas of 31 Dec 2023 | 526.00k | 1.49% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 445.49k | 1.27% |
| Morant Wright Management Ltd.as of 30 Sep 2024 | 442.00k | 1.26% |
| Nikko Asset Management Co., Ltd.as of 04 Oct 2024 | 269.60k | 0.77% |
| Daiwa Asset Management Co. Ltd.as of 30 Sep 2024 | 260.90k | 0.74% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 187.20k | 0.53% |
| Gutmann KAGas of 28 Jun 2024 | 175.50k | 0.50% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 03 Oct 2024 | 114.70k | 0.33% |
